121 related articles for article (PubMed ID: 7583546)
1. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene.
Zhang H; Reymer PW; Liu MS; Forsythe IJ; Groenemeyer BE; Frohlich J; Brunzell JD; Kastelein JJ; Hayden MR; Ma Y
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1695-703. PubMed ID: 7583546
[TBL] [Abstract][Full Text] [Related]
2. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
4. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
5. The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.
Evans D; Beil FU
BMC Med Genet; 2007 Aug; 8():56. PubMed ID: 17727701
[TBL] [Abstract][Full Text] [Related]
6. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.
Sijbrands EJ; Hoffer MJ; Meinders AE; Havekes LM; Frants RR; Smelt AH; De Knijff P
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2722-9. PubMed ID: 10559017
[TBL] [Abstract][Full Text] [Related]
7. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
Ma Y; Ooi TC; Liu MS; Zhang H; McPherson R; Edwards AL; Forsythe IJ; Frohlich J; Brunzell JD; Hayden MR
J Lipid Res; 1994 Jun; 35(6):1066-75. PubMed ID: 8077845
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
Perron P; Brisson D; Santuré M; Blackburn P; Bergeron J; Vohl MC; Després JP; Gaudet D
J Endocrinol Invest; 2007; 30(7):551-7. PubMed ID: 17848837
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
März W; Hoffmann MM; Scharnagl H; Fisher E; Chen M; Nauck M; Feussner G; Wieland H
J Lipid Res; 1998 Mar; 39(3):658-69. PubMed ID: 9548597
[TBL] [Abstract][Full Text] [Related]
10. A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.
Mailly F; Tugrul Y; Reymer PW; Bruin T; Seed M; Groenemeyer BF; Asplund-Carlson A; Vallance D; Winder AF; Miller GJ
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):468-78. PubMed ID: 7749858
[TBL] [Abstract][Full Text] [Related]
11. A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
Ishimura-Oka K; Semenkovich CF; Faustinella F; Goldberg IJ; Shachter N; Smith LC; Coleman T; Hide WA; Brown WV; Oka K
J Lipid Res; 1992 May; 33(5):745-54. PubMed ID: 1619366
[TBL] [Abstract][Full Text] [Related]
12. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase gene mutations in coronary artery disease.
Minnich A; Baloukas J; Roederer G; Lussier-Cacan S; Davignon J; Genest J
Can J Cardiol; 1998 May; 14(5):711-6. PubMed ID: 9627528
[TBL] [Abstract][Full Text] [Related]
14. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Minnich A; Kessling A; Roy M; Giry C; DeLangavant G; Lavigne J; Lussier-Cacan S; Davignon J
J Lipid Res; 1995 Jan; 36(1):117-24. PubMed ID: 7706936
[TBL] [Abstract][Full Text] [Related]
16. Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene.
Ma Y; Liu MS; Ginzinger D; Frohlich J; Brunzell JD; Hayden MR
J Clin Invest; 1993 May; 91(5):1953-8. PubMed ID: 8486765
[TBL] [Abstract][Full Text] [Related]
17. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.
Kobayashi J; Sasaki N; Tashiro J; Inadera H; Saito Y; Yoshida S
Biochem Biophys Res Commun; 1993 Mar; 191(3):1046-54. PubMed ID: 8096693
[TBL] [Abstract][Full Text] [Related]
20. Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy.
Mailly F; Palmen J; Muller DP; Gibbs T; Lloyd J; Brunzell J; Durrington P; Mitropoulos K; Betteridge J; Watts G; Lithell H; Angelico F; Humphries SE; Talmud PJ
Hum Mutat; 1997; 10(6):465-73. PubMed ID: 9401010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
